Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
01/29/2003 | EP0754175B1 Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides |
01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
01/29/2003 | CN1394143A Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
01/29/2003 | CN1100055C Piperazine and piperidine compounds |
01/28/2003 | US6512137 Synthesis method of nitroxymethylphenyl esters of aspirin derivatives |
01/28/2003 | US6512135 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate |
01/28/2003 | US6512124 N-(3,5-bis(4-hydroxybenzoyl)benzene)-4-fluoroisophthalimide. Aromatic polyimides (Pls) are well known, high-performance materials with widespread applications in the aerospace and electronics industries due to their excellent thermomechanical |
01/28/2003 | US6512123 Antiproliferative agents |
01/28/2003 | US6512002 Methods of treatment for premature ejaculation in a male |
01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
01/23/2003 | WO2003007071A2 Novel nonlinear optical compounds and polymers |
01/23/2003 | WO2003007070A1 Novel nonlinear optical polymers incorporating amines |
01/23/2003 | WO2003007069A2 Novel nonlinear optical polymers |
01/23/2003 | WO2003006670A2 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors |
01/23/2003 | WO2003006430A1 Taxol enhancer compounds |
01/23/2003 | WO2003006429A1 Synthesis of taxol enhancers |
01/23/2003 | WO2003006428A1 Taxol enhancer compounds |
01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
01/23/2003 | WO2003006061A1 Medicinal compositions for opthalmic use |
01/23/2003 | WO2003006011A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors |
01/23/2003 | WO2003005970A2 Carvedilol polymorph |
01/23/2003 | WO2002053535A3 Process for making amlodipine, derivatives thereof, and precursors therefor |
01/23/2003 | WO2002041835A3 Estrogen receptor modulators |
01/23/2003 | WO2002036562A3 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
01/23/2003 | WO2002034760A3 Compounds and methods |
01/23/2003 | WO2002022559A3 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
01/23/2003 | WO2002009760A3 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
01/23/2003 | US20030018062 Deacetylase inhibitors |
01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
01/23/2003 | US20030018056 Sodium channel moderators; cardiovascular disorders; antidiabetic agents |
01/23/2003 | US20030018053 Substituted indolealkanoic acids |
01/23/2003 | US20030018016 Cell adhesion inhibitors |
01/23/2003 | US20030017361 Organometallic complexes as phosphorescent emitters in organic LEDs |
01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
01/23/2003 | CA2453476A1 Medicinal compositions for opthalmic use |
01/23/2003 | CA2453415A1 Synthesis of taxol enhancers |
01/23/2003 | CA2452391A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors |
01/22/2003 | EP1277752A1 Process for producing optically active sulfoxide derivative |
01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
01/22/2003 | EP1277736A1 Novel bicyclic compounds |
01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
01/22/2003 | EP1276721A2 Methylation of indole compounds using dimethyl carbonate |
01/22/2003 | EP1276720A2 2-acyl indol derivatives and their use as anti-tumour agents |
01/22/2003 | EP1276714A2 Cyclic carboxylic acids as integrin antagonists |
01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
01/22/2003 | EP1030838B1 Method of synthesis of pyrrole amides |
01/22/2003 | EP0983247B1 Method for producing aromatic bisimides |
01/22/2003 | EP0952978B1 Metallocenes and catalysts for olefin-polymerisation |
01/22/2003 | EP0909174A4 Treatment of cystic disease with tnf-alpha |
01/22/2003 | CN1392140A Organic compound with di-4-dicyan methyl olefine pyranoid ring and its synthetic method and use |
01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
01/22/2003 | CN1099413C Certain fused N-pyrrolylaniline: new class of GABA brain receptor ligand |
01/21/2003 | US6509476 Process for preparing N-benzyl indoles |
01/21/2003 | US6509475 Friedel-Crafts acylation catalyzed by Lewis acid alkylaluminum dichloride; chemical reduction, salt formation |
01/21/2003 | US6509474 Method of lithiating five membered heterocycles |
01/21/2003 | US6509467 Of iminium salts using transition metal complex catalyst |
01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
01/21/2003 | US6509365 Useful as inhibitors of poly(ADP-ribose)polymerase and for the production of drugs. |
01/21/2003 | US6509357 1-aryl or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
01/21/2003 | US6509340 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands |
01/21/2003 | US6508753 Chiral ligands for asymmetric catalysis |
01/17/2003 | WO2002006214A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
01/17/2003 | CA2415954A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
01/16/2003 | WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents |
01/16/2003 | WO2003004466A2 Dye-sulfenates for dual phototherapy |
01/16/2003 | WO2003004458A1 New compounds |
01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
01/16/2003 | WO2003004018A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
01/16/2003 | WO2002050034A3 Tetracyclic carbazole derivates and their use as spla2 inhibitors |
01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
01/16/2003 | WO2002028832A3 Diindolylmethane and c-substituted diindolylmethane compositions and methods for the treatment of multiple cancers |
01/16/2003 | WO2002006228A1 Process for producing 5-fluorooxyindole and for producing intermediate therefor |
01/16/2003 | WO2001062705A3 Aminoalcohol derivatives |
01/16/2003 | US20030013875 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
01/16/2003 | US20030013861 E-isomeric fullerene derivatives |
01/16/2003 | US20030013722 Piperazinyl-isatins |
01/16/2003 | US20030013717 Cyclooxygenase inhibitor |
01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
01/16/2003 | US20030013603 Catalyst for oxidation, carbonylation, nitration, sulfonation |
01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
01/16/2003 | CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents |
01/16/2003 | CA2452211A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
01/16/2003 | CA2416397A1 Process for producing 5-fluorooxyindole and for producing intermediate therefor |
01/15/2003 | EP1275730A1 Process for producing optically active 7-substituted-3-(2-aminopropyl)indole derivatives and intermediates for producing the same |
01/15/2003 | EP1275644A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
01/15/2003 | EP1275630A1 Process for producing substituted aromatic compound |
01/15/2003 | EP1274701A1 Chemical compounds |
01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
01/15/2003 | EP0862571B1 Herbicidal sulfonamides |
01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
01/15/2003 | CN1391557A 6-position substituted indoline, production and use thereof as medicament |
01/15/2003 | CN1391556A IL-8 receptor antagonists |